Dr Loghavi on the Expansion of Genetically-Defined Subtypes in AML
September 20th 2023Sanam Loghavi, MD, discusses the expansion of genetically-defined categories of acute myeloid leukemia in the World Health Organization classification, and how this affects the diagnosis of patients in this space.
Read More
Higher-Risk MDS: First- and Second-Line Therapies and Case 3 Presentation/Discussion
March 2nd 2023The panel turns their focus to higher-risk MDS, starting with a discussion of first- and second-line treatment options, followed by a third and final case presentation and discussion led by Dr Platzbecker.
Read More
First-Line Treatment Options for Lower-Risk MDS
January 26th 2023Thomas Cluzeau, MD, PhD provides an overview of first-line treatment options for symptomatic anemia in patients with lower-risk MDS, followed by a discussion of panelists’ treatment patterns and dosing strategies across the globe.
Read More
MDS: Typical Patient Presentation, Diagnostic Process, and Evolving Terminology
January 18th 2023Moderator Rami Komrokji, MD, introduces the panel and invites expert pathologist Sanam Loghavi, MD to lead a discussion on the typical patient presentation and diagnostic process in MDS, which was recently renamed as ‘myelodysplastic neoplasms’ in the 2022 5th edition of the World Health Organization (WHO) classification of the disease state.
Read More